Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07146802

Personalized Metacognitive Training for Psychosis: A Randomized Controlled Trial

Towards a Personalized Medicine Approach to Psychological Treatment for Psychosis

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
51 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study aims to compare the efficacy of classical Metacognitive Training (MCT) and personalized Metacognitive Training (P-MCT) for individuals with psychosis. MCT is a psychoeducational program derived from cognitive-behavioral therapy (CBT) that targets cognitive biases associated with psychotic symptoms. The goal is to assess which intervention is more effective to improve the overall functioning of individuals with psychosis. The study will use machine learning to personalize the treatment approach and evaluate its impact on clinical symptoms, cognitive functions, and quality of life.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMetacognitive Training (MCT) for psychosisMCT for psychosis is based on the theoretical foundations of the cognitive-behavioral model of schizophrenia, but it employs a somewhat different therapeutic approach. The program is comprised of ten modules targeting common cognitive errors, problem-solving biases as well as emotional problems in schizophrenia. These errors and biases may, on their own or in combination, culminate in the establishment of false beliefs to the point of delusions. The aim of the sessions is to raise the participants' awareness of these distortions and to prompt them to critically reflect on, expand upon, and change their current repertoire of problem solving. In addition to the sessions, the program includes homework tasks to reinforce the skills learned between sessions.

Timeline

Start date
2025-10-01
Primary completion
2027-04-01
Completion
2027-04-01
First posted
2025-08-28
Last updated
2025-09-15

Source: ClinicalTrials.gov record NCT07146802. Inclusion in this directory is not an endorsement.